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LEV patients previously received more CM (41% no
CM; 24% 1 CM; 34% 1 CM), after treatment the per-
cent with 1 CM declined to 28%. Their leukotriene
modifier use increased from 22% to 25% while long-act-
ing bronchodilator use decreased from 13% to 10%. In
patients without prior CM, mean charges declined by
similar amounts in both groups (LEV: $360, RAC: $306)
following treatment. In patients with 1 CM, LEV was as-
sociated with a $116 reduction despite a $121 increase in
pharmacy charges while RAC was associated with a $22
decrease. In patients with 1 CM, LEV was associated
with a $435 reduction in mean charges while RAC was
associated with a $311 increase. CONCLUSIONS: Asth-
matic patients treated with LEV required no additional
CM and some patients reduced the number of CM. Cost
reductions associated with LEV increased with severity.
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Preliminary evidence suggests that levalbuterol (LEV),
the therapeutically active isomer of albuterol, can im-
prove clinical outcomes while reducing health care costs
compared to racemic albuterol (RAC). OBJECTIVE: Ex-
plore the impact of LEV versus RAC on resource utiliza-
tion, co-medication use, and cost of therapy in asthmat-
ics. METHODS: Claims data on patients prescribed LEV
and RAC were obtained from the PharMetrics Integrated
Outcomes Database. Age- and sex-matched samples of
patients initiating therapy with LEV or RAC (no pre-
scriptions for either agent in prior 6 months) were se-
lected and their asthma-related charges were assessed
over 6 months following the initial prescription. RE-
SULTS: 544 LEV-treated patients were identified and
matched to 544 RAC-treated patients. 70% of all pa-
tients were 12 years of age. 32% of RAC patients and
59% of LEV patients received asthma controller medica-
tion during the prior 6 months. Mean asthma-related
(pharmacy and medical) charges during the prior 6
months were $872 versus $587 in the LEV and RAC
groups respectively. During the 6 months follow-up pe-
riod, controller medication use increased among RAC pa-
tients to 59%, while use among LEV patients remained
unchanged. Overall mean charges decreased by $298 for
LEV and $61 for RAC. In patients receiving concomitant
controller medications, LEV was associated with a $247
decline in charges versus a $116 increase for RAC.
Among patients treated in primary care (pediatricians,
family practitioners, and internists), the reduction in
mean charges was $262 for LEV, while RAC was associ-
ated with a $180 increase. CONCLUSIONS: 1) LEV was
prescribed to patients who were “sicker” than those pre-
scribed RAC; 2) Patients treated with RAC, but not LEV,
tended to require additional controller medications; 3)
LEV was associated with greater reduction in total cost
compared to RAC, which in “sicker” and primary care
patients was associated with increased cost.
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BACKGROUND: Previous studies have shown that anti-
biotics are prescribed for nasopharyngitis, upper respira-
tory infection, and acute bronchitis approximately 40–
80% of the time. Because these conditions tend to be vi-
ral in nature, the efficacy of treating with antibiotics is
questionable at best and potentially dangerous at worst.
OBJECTIVE: The purpose of this study is to determine
those physician characteristics that are associated with
inappropriate antibiotic prescribing. METHOD: This
study reviewed the antibiotic prescribing patterns of 138
physicians treating members of the NJ Carpenters Funds
from 1997–1998 for upper respiratory infection and
acute bronchitis. Using logistic regression analysis, the
rate of antibiotic prescribing was used to evaluate the po-
tential relationship with the following physician charac-
teristics: specialty, year of graduation from medical
school, gender, ABMS (American Board of Medical Spe-
cialties Status), type of practice (group versus solo), and
foreign versus domestic medical graduate status. RE-
SULTS: The results indicate that there were significantly
disparate rates of prescribing by physician specialty, as
compared to pediatricians: family practitioners (OR
3.296 95% CI 2.459–4.419), internal medicine (OR 1.67
95% CI 1.145–2.436) and other (primarily general prac-
tice) (OR 1.421 95% CI 1.008–2.003). In the pediatric
subgroup, there was a definite trend in inappropriate an-
tibiotic prescribing according to the year of graduation
from medical school (1950s: OR 3.779 95% CI 1.774–
8.051; 1960s: OR 3.088 95% CI 1.994–4.783, and
1970s: OR 1.713 95% CI 1.123–2.614). CONCLU-
SION: Although some of these findings are significant,
the majority of physician characteristics reviewed were
not significantly related to inappropriate antibiotic pre-
scribing. The findings may be indicative of the fact that
this problem is widespread and multi-faceted. This study
suggests that there is a definite need for education of both
patients and physicians to change long held beliefs that
antibiotics are a cure-all for all types of infections, and
that there are no negative consequences to inappropriate
antibiotic use.
